Clinical Trial

Effects of Probiotic Supplementation on Stress and Anxiety in Students

Study acronym: PROfoS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized, double-blind, placebo-controlled study evaluates the efficacy and safety of an 8-week probiotic supplementation (Lactobacillus plantarum LP140 and Bifidobacterium breve BB010 in total daily dose 1 × 10¹⁰ CFU or matching placebo) in reducing perceived stress and anxiety, and improvement related psychological parameters in healthy university students during the examination period. The primary outcome is the change in Perceived Stress Scale (PSS-10) score at week 5 and week 8 of interevention compared to placebo. The secondary outcomes are the changes in DASS-21 subscales (Stress, Anxiety, Depression), State-Trait Anxiety Inventory - State version scale (STAI-S), Sense of Coherence Scale (SOC-29), Pittsburgh Sleep Quality Index (PSQI), self-reported gastrointestinal symptoms (Likert scale) and incidence of adverse events during the 8-week lasting interventional study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-10.
Trial Details
NCT Number NCT07470645
Lead Sponsor Nordic Biotic Sp. z o.o.
Collaborators: Wörwag Pharma GmbH & Co. KG
Conditions Stress, Anxiety, Sleep, Gastro-intestinal Symptoms in Healthy Subjects
Enrollment 200 participants
Start Date 2026-04-20
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-17